Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01664676Phase 4Completed
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide with Placebo (2 arms). Primary endpoint: Glomerular Filtration Rate. Started Dec 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01664676.